We only have this paper's title and publication details.
Read it at the sourcePost-hoc analysis compares clinical outcomes in advanced soft tissue sarcomas, implying treatment effectiveness of immune checkpoint inhibitors and chemotherapy.
Figure S3. Post-hoc analysis comparing stage 1 and stage 2 clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Wilky et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: